English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Rational Design and Asymmetric Synthesis of Potent and Neurotrophic Ligands for FK506-Binding Proteins (FKBPs)

MPS-Authors
/persons/resource/persons147402

Pomplun,  Sebastian
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons186011

Wang,  Yansong
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons182844

Kirschner,  Alexander
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80406

Kozany,  Christian
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80356

Hausch,  Felix
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Pomplun, S., Wang, Y., Kirschner, A., Kozany, C., Bracher, A., & Hausch, F. (2015). Rational Design and Asymmetric Synthesis of Potent and Neurotrophic Ligands for FK506-Binding Proteins (FKBPs). ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 54(1), 345-348. doi:10.1002/anie.201408776.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0029-032A-7
Abstract
To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro-(S)-C-5-branched [4.3.1] aza-amide bicycles was developed. The key step of the synthesis is an HF-driven N-acyliminium cyclization. Functionalization of the C(5)moiety resulted in novel protein contacts with the psychiatric risk factor FKBP51, which led to a more than 280-fold enhancement in affinity. The most potent ligands facilitated the differentiation of N2a neuroblastoma cells with low nanomolar potency.